Study ID: BDB-AS-304

Study Title

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

Teva Identifier

BDB-AS-304

ClinicalTrials.gov Identifier

NCT02040779

Study Status

Completed

Trial Condition(s)

Persistent Asthma

Interventions

Drug: Beclomethasone dipropionate breath-actuated inhaler | Drug: Placebo breath-actuated inhaler | Drug: albuterol/salbutamol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

December 26, 2013 - December 24, 2014

Phase

Phase 3

Study Type

Interventional